SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences:Guggenheim Emerging Outlook: Biotech Summit 2026, New York, NYFormat – Fireside chat and 1x1 investor meetingsDate and Time – Wednesday, Feb. 11, 2026 at 3:00pm ETPiper Sandler Virtual Novel Targets in Immunology Symposium, VirtualFormat – Fireside chatDate and Time – Thursday, Feb. 12, 2026 at 12:30pm ETTD Cowen 46th Annual Health Care Conference, Boston, MAFormat – Fireside chat and 1x1 investor meetingsDate and Time ...Full story available on Benzinga.com